Pantecta Control
pantoprazole
Table of contents
Withdrawn
This medicine is now withdrawn from use in the European Union.
Overview
The marketing authorisation for Pantecta Control has been withdrawn at the request of the marketing-authorisation holder.
This EPAR was last updated on 15/11/2016
Authorisation details
| Product details | |
|---|---|
| Name |
Pantecta Control
|
| Agency product number |
EMEA/H/C/001099
|
| Active substance |
pantoprazole
|
| International non-proprietary name (INN) or common name |
pantoprazole
|
| Therapeutic area (MeSH) |
Gastroesophageal Reflux
|
| Anatomical therapeutic chemical (ATC) code |
A02BC02
|
| Publication details | |
|---|---|
| Marketing-authorisation holder |
Takeda GmbH
|
| Revision |
7
|
| Date of issue of marketing authorisation valid throughout the European Union |
12/06/2009
|
| Contact address |
Byk-Gulden-Strasse 2
D-78467 Konstanz Germany |
Product information
19/09/2016 Pantecta Control - EMEA/H/C/001099 - IG/0634
This medicine’s product information is available in all official EU languages.
Select ‘available languages’ to access the language you need.
Product information documents contain:
- summary of product characteristics (annex I);
- manufacturing authorisation holder responsible for batch release (annex IIA);
- conditions of the marketing authorisation (annex IIB);
- labelling (annex IIIA);
- package leaflet (annex IIIB).
You can find product information documents for centrally authorised human medicines on this website. For centrally authorised veterinary medicines authorised or updated from February 2022, see the Veterinary Medicines Information website.
Pharmacotherapeutic group
Pharmacotherapeutic group
Proton pump inhibitors
Therapeutic indication
Therapeutic indication
Short-term treatment of reflux symptoms (e.g. heartburn, acid regurgitation) in adults.